• COVID-19: A Multidimensional Response

    COVID-19 disease is caused by the SARS-CoV-2 virus, first detected in November-December 2019 in Wuhan, China. Thus far, more than 7 million people have been infected with the novel coronavirus across the globe, and the count is increasing with every passing day. Even though it causes severe respiratory problems, the majority of patients show mild symptoms, and pathogenesis is under investigation. Although several drugs are being developed and many of them are undergoing clinical trials, currently there are no approved drugs/vaccines to cure this disease. Personal hygiene and social distancing are important means to prevent the spread of this disease. With the advancements in scientific research, humankind is hoping to find a potent drug/vaccine for this disease at the earliest. The health care professionals and scientific community are at their maximum in combating this viral infection. In this book, an attempt is made to compile various aspects of COVID-19 in a single platform, which include aetiology, epidemiology, its clinical manifestations, diagnosis, pathological, clinical and therapeutic facets, comorbidities, risk factors, and the essential precautionary measures. This book comprises around 29 chapters contributed by various experts from research and clinical backgrounds.

  • Affordable and Effective Drug Delivery (Varanasi to Manipal Research Journey)

    Affordable and Effective Drug Delivery book is a compilation of the research works guided by Dr N Udupa in the area of drug delivery. Over four decades, Dr Udupa has shared his proficiency and expertise to build up, strengthen and widen the knowledge and information about the development and delivery of various therapeutic dosage forms. Research work that he undertook over several years is presented briefly as a compilation of his research activities involving Novel Drug Delivery System, Liposomes, Niosomes, Nutraceuticals, etc. The book will not only inspire many young researchers but, will also be a guiding force to senior researchers in the academia and industry. More than 500 publications with over 5000 citations, about eight patents, half-a-dozen books, and research guidance of over 100 research scholars is a definitive testimony of his exemplary contribution to pharma education and research.

  • A Concise Textbook of Drug Regulatory Affairs

    This book has 12 chapters covering nearly all the areas of Drug Regulatory Affairs. Various aspects of Drug Regulatory Affairs such as new drug approval procedure, pharmacovigilance, product recall, evolution of drug regulations in the United States of America (USA) and process of drug approval in the USA and European Union, bioequivalence regulations, electronic Common Technical Documents (eCTD), environmental regulations, orphan drugs pharmaceutical pricing and control policy, Pharmacovigilance system in India and the USA, Product Recall, regulations of pharmaceutical drug promotion and Pharmacy Practice regulations are covered in this book. As a whole, the book is a comprehensive reference book on regulatory affairs and will be very useful for the practicing professionals and students alike.